Enviado: 8/12/2005 19:51Vai assim e com recomendações positivas
Pfizer (NYSE:PFE - News)
Morningstar Rating: 5 Stars
Economic Moat: Wide
Risk Rating: Average
From the Analyst Report: Pfizer's massive size and scale give it significant competitive advantages. Its formidable salesforce is the largest in the industry, providing vital muscle in penetrating the vast global physician network. Pfizer's existing drug portfolio is first-rate. Ten products hold dominant market positions in such key therapeutic classes as cholesterol control, anti-infectives, and erectile dysfunction.
Pfizer (NYSE:PFE - News)
Morningstar Rating: 5 Stars
Economic Moat: Wide
Risk Rating: Average
From the Analyst Report: Pfizer's massive size and scale give it significant competitive advantages. Its formidable salesforce is the largest in the industry, providing vital muscle in penetrating the vast global physician network. Pfizer's existing drug portfolio is first-rate. Ten products hold dominant market positions in such key therapeutic classes as cholesterol control, anti-infectives, and erectile dysfunction.